Evidence map›Paper›PMID 30442329›Full record

Trial reportBehaviour research and therapy2019

Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.

Julia D Buckner, Michael J Zvolensky, Anthony H Ecker, Norman B Schmidt, Elizabeth M Lewis, Daniel J Paulus, Paula Lopez-Gamundi, Kathleen A Crapanzano, Jafar Bakhshaie

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Behaviour research and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Opioid and cannabis co-use: The role of opioid use to cope with negative affect.Journal of substance use and addiction treatment · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Julia D BucknerLouisiana State University, Baton Rouge, LA, United States. Electronic address: jbuckner@lsu.edu.
Michael J ZvolenskyUniversity of Houston, Houston, TX, United States; University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Anthony H EckerSouth Central Mental Illness Research Education and Clinical Center, Houston, TX, United States; Baylor College of Medicine, Houston, TX, United States.
Norman B SchmidtFlorida State University, Tallahassee, FL, United States.
Elizabeth M LewisLouisiana State University, Baton Rouge, LA, United States.
Daniel J PaulusUniversity of Houston, Houston, TX, United States.
Paula Lopez-GamundiUniversity of Texas Health Science Center at Houston, Houston, TX, United States.
Kathleen A CrapanzanoLouisiana State University Health Sciences Center, Baton Rouge, LA, United States.
Jafar BakhshaieUniversity of Houston, Houston, TX, United States.
Louisiana State University · USUniversity of Houston · USBaylor College of Medicine · USFlorida State University · USLouisiana State University Health Sciences Center New Orleans · USThe University of Texas Health Science Center at Houston · USThe University of Texas MD Anderson Cancer Center · US

Funding

Integrated CBT for Cannabis Dependence with Co-occurring Anxiety DisordersR34DA031937 · NIDA · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI BUCKNER, JULIA D, ZVOLENSKY, MICHAEL J. · 2012 to 2014
$624k
NIDA NIH HHS R34 DA031937
6 · The paper itself

Abstract

Cannabis use disorder (CUD) is the most common illicit substance use disorder and individuals with CUD have high rates of comorbid anxiety disorders. Comorbidity between CUD and anxiety disorders is of public health relevance given that although motivation enhancement therapy (MET) combined with cognitive-behavioral therapy (CBT) is an efficacious intervention for CUD, outcomes are worse for patients with elevated anxiety. The current study tested the acceptability and efficacy of the integration of a transdiagnostic anxiety CBT (i.e., treatment of patients with any anxiety disorder) with MET-CBT (integrated cannabis and anxiety reduction treatment, or ICART) for CUD compared to MET-CBT alone. Treatment-seeking cannabis users (56.4% male, M

Indexed as

AdolescentAdultAnxiety DisordersCognitive Behavioral TherapyDiagnosis, Dual (Psychiatry)FemaleHumansMaleMarijuana UsePilot ProjectsTreatment OutcomeYoung AdultAnxiety disordersCannabisDual diagnosisIntegrated treatmentMarijuana

Identifiers

PMID30442329
PMCPMC6409106
OpenAlexW2898536234

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.